Stock RNAC CARTESIAN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Cartesian Therapeutics, Inc.

Equities

RNAC

US8162123025

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
21.17 USD -3.16% Intraday chart for Cartesian Therapeutics, Inc. -17.30% +2.36%
Apr. 23 Leerink Partners Starts Cartesian Therapeutics With Outperform Rating, $39 Price Target MT
Mar. 14 Cartesian Therapeutics, Inc Receives Notice from Audentes Therapeutics, Inc of Astellas? Termination of the License and Development Agreement CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CARTESIAN THERAPEUTICS, INC.
Bio Therapeutic Drugs
-3.16%-17.30%+2.36% - - 377M
Bullish
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. RNAC Stock
  4. Charts Cartesian Therapeutics, Inc.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW